ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
CNS Pharmaceuticals Inc

CNS Pharmaceuticals Inc (CNSP)

0,1058
0,0102
(10,67%)
Geschlossen 27 Januar 10:00PM
0,1064
0,0006
(0,57%)
Nach Börsenschluss: 1:58AM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
0,1064
Gebot
0,1063
Fragen
0,1064
Volumen
30.004.930
0,10 Tagesbereich 0,1129
0,0955 52-Wochen-Bereich 29,00
Marktkapitalisierung
Handelsende
0,0956
Handelsbeginn
0,104
Letzte Trade
8
@
0.10635
Letzter Handelszeitpunkt
Finanzvolumen
US$ 3.204.839
VWAP
0,10681
Durchschnittliches Volumen (3 Mio.)
15.486.390
Ausgegebene Aktien
57.486.706
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,34
Gewinn pro Aktie (EPS)
-0,33
Erlöse
-
Nettogewinn
-18,85M

Über CNS Pharmaceuticals Inc

CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of ... CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Carson City, Nevada, USA
Gegründet
-
CNS Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CNSP. The last closing price for CNS Pharmaceuticals was US$0,10. Over the last year, CNS Pharmaceuticals shares have traded in a share price range of US$ 0,0955 to US$ 29,00.

CNS Pharmaceuticals currently has 57.486.706 shares in issue. The market capitalisation of CNS Pharmaceuticals is US$5,50 million. CNS Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.34.

CNSP Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0006-0.5607476635510.1070.110.098120744390.10343038CS
4-0.0083-7.236268526590.11470.16270.098358694810.1160071CS
12-0.0155-12.7153404430.12190.16270.0957154863900.11666904CS
26-0.9637-90.05700401831.07011.240.0955146479510.14389628CS
52-28.0086-99.621554330428.115290.095579676880.56966502CS
156-974.8936-99.989087179597510050.0955318250442.09993588CS
260-6689.8936-99.9984095665669084300.09552147371417.65553271CS

CNSP - Frequently Asked Questions (FAQ)

What is the current CNS Pharmaceuticals share price?
The current share price of CNS Pharmaceuticals is US$ 0,1064
How many CNS Pharmaceuticals shares are in issue?
CNS Pharmaceuticals has 57.486.706 shares in issue
What is the market cap of CNS Pharmaceuticals?
The market capitalisation of CNS Pharmaceuticals is USD 5,5M
What is the 1 year trading range for CNS Pharmaceuticals share price?
CNS Pharmaceuticals has traded in the range of US$ 0,0955 to US$ 29,00 during the past year
What is the PE ratio of CNS Pharmaceuticals?
The price to earnings ratio of CNS Pharmaceuticals is -0,34
What is the reporting currency for CNS Pharmaceuticals?
CNS Pharmaceuticals reports financial results in USD
What is the latest annual profit for CNS Pharmaceuticals?
The latest annual profit of CNS Pharmaceuticals is USD -18,85M
What is the registered address of CNS Pharmaceuticals?
The registered address for CNS Pharmaceuticals is 112 NORTH CURRY STREET, CARSON CITY, NEVADA, 89703
What is the CNS Pharmaceuticals website address?
The website address for CNS Pharmaceuticals is www.cnspharma.com
Which industry sector does CNS Pharmaceuticals operate in?
CNS Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
EVAXEvaxion Biotech AS
US$ 5,99
(64,56%)
55,41M
ELABPMGC Holdings Inc
US$ 3,0901
(56,07%)
76,48M
PCLAPicoCELA Inc
US$ 4,60
(49,35%)
3,75M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
GODNUGolden Star Acquisition Corporation
US$ 3,11
(-75,82%)
17,51k
GODNGolden Star Acquisition Corporation
US$ 2,93
(-65,67%)
902,76k
NXTTNext Technology Holding Inc
US$ 1,37
(-54,93%)
2,56M
SGLYSingularity Future Technology Ltd
US$ 1,625
(-38,45%)
917,77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90,11
(-38,07%)
8
ACONAclarion Inc
US$ 0,0557
(28,94%)
811,91M
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
RIMEAlgorhythm Holdings Inc
US$ 0,0357
(4,69%)
284,97M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
NVDANVIDIA Corporation
US$ 142,62
(-3,12%)
232,88M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock